Values First Advisors Inc. Has $762,000 Position in Shockwave Medical, Inc. (NASDAQ:SWAV)

Values First Advisors Inc. boosted its stake in shares of Shockwave Medical, Inc. (NASDAQ:SWAV) by 27.3% in the fourth quarter, HoldingsChannel reports. The firm owned 4,000 shares of the company’s stock after purchasing an additional 859 shares during the quarter. Values First Advisors Inc.’s holdings in Shockwave Medical were worth $762,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors also recently modified their holdings of SWAV. Lindbrook Capital LLC raised its position in Shockwave Medical by 64.8% during the third quarter. Lindbrook Capital LLC now owns 150 shares of the company’s stock valued at $30,000 after purchasing an additional 59 shares in the last quarter. EverSource Wealth Advisors LLC boosted its holdings in shares of Shockwave Medical by 297.4% during the 3rd quarter. EverSource Wealth Advisors LLC now owns 155 shares of the company’s stock worth $31,000 after buying an additional 116 shares in the last quarter. PenderFund Capital Management Ltd. acquired a new stake in Shockwave Medical in the first quarter worth $41,000. Operose Advisors LLC acquired a new position in Shockwave Medical during the 3rd quarter worth approximately $49,000. Finally, Northwestern Mutual Wealth Management Co. raised its position in shares of Shockwave Medical by 43.9% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 331 shares of the company’s stock worth $68,000 after purchasing an additional 101 shares during the period. Institutional investors own 95.35% of the company’s stock.

Insider Activity

In other Shockwave Medical news, Director Frederic H. Moll sold 60,000 shares of the company’s stock in a transaction that occurred on Wednesday, February 21st. The stock was sold at an average price of $257.39, for a total value of $15,443,400.00. Following the completion of the sale, the director now owns 287,521 shares of the company’s stock, valued at $74,005,030.19. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. In related news, Director Frederic H. Moll sold 60,000 shares of the firm’s stock in a transaction that occurred on Wednesday, February 21st. The stock was sold at an average price of $257.39, for a total transaction of $15,443,400.00. Following the transaction, the director now directly owns 287,521 shares in the company, valued at approximately $74,005,030.19. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, VP Trinh Phung sold 599 shares of the business’s stock in a transaction dated Thursday, February 22nd. The shares were sold at an average price of $259.24, for a total transaction of $155,284.76. Following the completion of the transaction, the vice president now owns 31,031 shares in the company, valued at approximately $8,044,476.44. The disclosure for this sale can be found here. In the last quarter, insiders have sold 115,813 shares of company stock worth $28,337,059. 3.40% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on SWAV. CL King began coverage on Shockwave Medical in a report on Wednesday. They issued a “buy” rating and a $368.00 target price on the stock. TheStreet upgraded shares of Shockwave Medical from a “c+” rating to a “b” rating in a report on Thursday, February 15th. Morgan Stanley reduced their price objective on shares of Shockwave Medical from $284.00 to $223.00 and set an “overweight” rating for the company in a research report on Monday, December 4th. Wells Fargo & Company boosted their target price on Shockwave Medical from $200.00 to $210.00 and gave the stock an “equal weight” rating in a research note on Friday, February 16th. Finally, Piper Sandler lifted their price target on Shockwave Medical from $275.00 to $290.00 and gave the stock an “overweight” rating in a report on Friday, February 16th. Two research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $271.44.

Shockwave Medical Stock Performance

Shares of NASDAQ SWAV traded up $3.02 during mid-day trading on Friday, hitting $325.63. The company had a trading volume of 814,504 shares, compared to its average volume of 698,070. The stock’s 50-day moving average price is $254.81 and its 200-day moving average price is $215.40. The company has a market capitalization of $12.18 billion, a price-to-earnings ratio of 84.14, a P/E/G ratio of 2.73 and a beta of 0.90. The company has a current ratio of 11.76, a quick ratio of 10.73 and a debt-to-equity ratio of 1.09. Shockwave Medical, Inc. has a 1 year low of $157.00 and a 1 year high of $331.58.

Shockwave Medical (NASDAQ:SWAV) last posted its earnings results on Thursday, February 15th. The company reported $1.16 earnings per share for the quarter, topping analysts’ consensus estimates of $0.92 by $0.24. The business had revenue of $202.98 million for the quarter, compared to analyst estimates of $199.43 million. Shockwave Medical had a net margin of 20.17% and a return on equity of 23.97%. Shockwave Medical’s revenue was up 41.0% on a year-over-year basis. During the same quarter in the prior year, the firm posted $3.71 EPS. On average, sell-side analysts forecast that Shockwave Medical, Inc. will post 4.89 earnings per share for the current year.

Shockwave Medical Company Profile

Shockwave Medical, Inc, a medical device company, develops and commercializes intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral and coronary vascular, and heart valve diseases in the United States and internationally. The company offers products for the treatment of peripheral artery disease (PAD), including M5 IVL catheter and M5+ IVL catheter, which are five-emitter catheters used in IVL system in medium-diameter vessels; S4 IVL catheter, a four-emitter catheter for use in IVL system in small-diameter vessels; and L6 IVL catheter, a six-emitter catheter used for IVL System in large diameter vessels.